Treating Type 2 Diabetes Mellitus (T2DM) in adults 65 years and older can result in high healthcare costs, but little is known as to why.
PurpleLab® partnered with a healthcare organization to help them understand cost variations and healthcare resource utilization (HCRU) patterns in Type 2 Diabetes Mellitus (T2DM) patients with at least 1 common comorbidity. The case study below will discuss using standardized pricing models and real-world data, over a one year period.